Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_assertion type Assertion NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_head.
- NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_assertion description "[The paradox of how breast carcinoma cells expressing these endogenous chemotaxis inhibitors are able to migrate is explained by their expression of vascular endothelial growth factor (VEGF), a NP1 ligand that competes with SEMA3A for receptor binding.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_provenance.
- NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_assertion evidence source_evidence_literature NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_provenance.
- NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_assertion SIO_000772 14500350 NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_provenance.
- NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_assertion wasDerivedFrom befree-20150227 NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_provenance.
- NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_assertion wasGeneratedBy ECO_0000203 NP841426.RAZvpxFpEpikTTNV0h19cFKXrhPqnX4Tmwxj47cpvCGk0130_provenance.